Krishnaswamy Yeleswaram

Chief Development Officer

Krishnaswamy Yeleswaram (Chief Development Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.5M of RAPP (50,160 sh across 3 lots, as filed), executed Aug 24.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.3M

shares × price, as filed

Last traded

Aug 25

Filed Aug 26

Median ADV $17.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

RAPP

Rapport Therapeutics, Inc. RAPP · 0 buys · 4 sells 4 filings

Recent filings

RAPPSALE Rapport Therapeutics, Inc. View filing → $2.5M
50,160 sh across 3 lots
Exec Aug 24
Filed Aug 26 · 4:00 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $809K
20,225 sh × $39.99
Exec Apr 17
Filed Apr 21 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $678K
19,365 sh across 2 lots
Exec Apr 13
Filed Apr 14 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $303K
10,115 sh × $29.99
Exec Mar 25
Filed Mar 26 · 5:30 PM ET